Collectively, obesity and systemic inflammation are associated with upregulation of immune checkpoints on T-cells, which is partially mediated via the immunomodulatory effects of leptin in pre-clinical tumour models and clinical studies. This evidence concerns the gene LEP and obesity disorder.